If it continues, GERD can cause scarring and narrowing of the esophagus and increase a persons risk of esophageal cancer.Results show that people taking GLP-1 drugs were 27% more likely to develop GERD and 55% more likely to have GERD complications, when compared to people taking SGLT-2 inhibitors.More than 90% of GERD complications involved Barrett esophagus, in which acid damage changes the tissue lining of the esophagus and increases cancer risk, researchers noted.We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use, researchers wrote.However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity.There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes, researchers wrote
Wirtz Baker JM, Pou SA, Niclis C, Haluszka E, Aballay LR
You can stick with the same area of the body or rotate areas each time
Managing Weight and Blood Sugar After Mounjaro Weight regain and deterioration in glycaemic control are common concerns after stopping Mounjaro, as the medication's effects on appetite suppression and insulin sensitivity will gradually diminish
You should not use Mounjaro if you have a personal or family history of a rare thyroid cancer (MEDULLARY thyroid carcinoma) or a genetic endocrine tumor syndrome, as medications like tirzepatide and other GLP-1 agonists carry a precaution for these